A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ

Journal of Proteomics

Volumn 73, Issue 2, 2009, Pages 352-356

  Tonack, Sarah ^a   Aspinall O'Dea, Mark ^a   Jenkins, Rosalind E ^b   Elliot, Victoria ^b   Murray, Seonaid ^a   Lane, Catherine S ^c   Kitteringham, Neil R ^b   Neoptolemos, John P ^a   Costello, Eithne ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Applied Biosystems   (United Kingdom)

Author keywords

Biomarker; Isobaric tags for relative and absolute quantification (iTRAQ); LC MS MS; Pancreatic cancer; Serum

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL PROTOCOL; HUMAN; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTIFICATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS;

BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEOMICS; RESEARCH DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 70449558565     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.07.009     Document Type: Article

References (13)

1. Wu W.W., Wang G., Baek S.J., and Shen R.F. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res 5 (2006) 651-658
2. Shadforth I.P., Dunkley T.P., Lilley K.S., and Bessant C. i-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 6 (2005) 145
3. Hergenroeder G., Redell J.B., Moore A.N., Dubinsky W.P., Funk R.T., Crommett J., et al. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma 25 (2008) 79-93
4. Song X., Bandow J., Sherman J., Baker J.D., Brown P.W., McDowell M.T., et al. iTRAQ experimental design for plasma biomarker discovery. J Proteome Res 7 (2008) 2952-2958
5. Ghaneh P., Costello E., and Neoptolemos J.P. Biology and management of pancreatic cancer. Gut 56 (2007) 1134-1152
6. Locker G.Y., Hamilton S., Harris J., Jessup J.M., Kemeny N., Macdonald J.S., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24 (2006) 5313-5327
7. Goonetilleke K.S., and Siriwardena A.K. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33 (2007) 266-270
8. Yan L., Tonack S., Smith R., Dodd S., Jenkins R.E., Kitteringham N., et al. Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer. J Proteome Res 8 (2009) 142-148
9. Cham B.E., and Knowles B.R. A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 17 (1976) 176-181
10. Yu K.H., Rustgi A.K., and Blair I.A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 4 (2005) 1742-1751
11. Deng R., Lu Z., Chen Y., Zhou L., and Lu X. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis. Pancreas 34 (2007) 310-317
12. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 845-867
13. http://www.moldiagpaca.eu/.